eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.
Research ArticleCancer
β1 Integrin Inhibition Elicits a Prometastatic Switch Through the TGFβ–miR-200–ZEB Network in E-Cadherin–Positive Triple-Negative Breast Cancer
- Hoa H. Truong1,*,
- Jiangling Xiong1,*,
- Veerander P. S. Ghotra1,
- Ella Nirmala1,
- Lizette Haazen1,
- Sylvia E. Le Dévédec1,
- Hayri E. Balcioğlu1,
- Shuning He2,
- B. Ewa Snaar-Jagalska2,
- Erno Vreugdenhil3,
- John H. N. Meerman1,
- Bob van de Water1, and
- Erik H. J. Danen1,†
- 1Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden 2333CC, the Netherlands.
- 2Department of Molecular Cell Biology, Institute of Biology, Leiden University, Leiden 2333CC, the Netherlands.
- 3Division of Medical Pharmacology, Leiden Academic Center for Drug Research, Leiden University, Leiden 2333CC, the Netherlands.
- ↵†Corresponding author. E-mail: e.danen{at}lacdr.leidenuniv.nl
-
↵* These authors contributed equally to this work.
See allHide authors and affiliations
Science Signaling 11 Feb 2014:
Vol. 7, Issue 312, pp. ra15
DOI: 10.1126/scisignal.2004751
Vol. 7, Issue 312, pp. ra15
DOI: 10.1126/scisignal.2004751
Hoa H. Truong
1Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden 2333CC, the Netherlands.
Jiangling Xiong
1Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden 2333CC, the Netherlands.
Veerander P. S. Ghotra
1Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden 2333CC, the Netherlands.
Ella Nirmala
1Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden 2333CC, the Netherlands.
Lizette Haazen
1Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden 2333CC, the Netherlands.
Sylvia E. Le Dévédec
1Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden 2333CC, the Netherlands.
Hayri E. Balcioğlu
1Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden 2333CC, the Netherlands.
Shuning He
2Department of Molecular Cell Biology, Institute of Biology, Leiden University, Leiden 2333CC, the Netherlands.
B. Ewa Snaar-Jagalska
2Department of Molecular Cell Biology, Institute of Biology, Leiden University, Leiden 2333CC, the Netherlands.
Erno Vreugdenhil
3Division of Medical Pharmacology, Leiden Academic Center for Drug Research, Leiden University, Leiden 2333CC, the Netherlands.
John H. N. Meerman
1Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden 2333CC, the Netherlands.
Bob van de Water
1Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden 2333CC, the Netherlands.
Erik H. J. Danen
1Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden 2333CC, the Netherlands.
Submit a Response to This Article
No eLetters have been published for this article.